Serendip Innovations won an award!
A modular plant virus-derived nanoparticle for drug vectorization Le CNRS et la start-up Serendip innovations ont récemment conclu des accords de licence exclusive. Le principe de la technologie : modifier un virus de plante pour qu’il serve à transporter des molécules utiles et à cibler spécifiquement certaines cellules. L’entreprise développe ainsi un vaccin thérapeutique visant […]
Serendip Innovations won an award!
Serendip Innovations won an award! Delighted to have participated on behalf of Angels Santé in this OUI (Oncology Upward Investment) investors jury as part of the MATWIN Meet2win congress. 10 great startups came to pitch…congratulations to Stromacare SAS (ceo Georges Rawadi ) and Serendip innovations (ceo Alexandre Hill ) who were rewarded…. and a very […]